Laurion Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-98,896
| Closed | -$1.81M | – | 166 |
|
|
2024
Q4 | $1.81M | Buy |
+98,896
| New | +$1.81M | 0.03% | 75 |
|
|
2020
Q4 | – | Sell |
-23,200
| Closed | -$957K | – | 404 |
|
|
2020
Q3 | $957K | Sell |
23,200
-12,527
| -35% | -$517K | 0.01% | 291 |
|
|
2020
Q2 | $1.73M | Buy |
+35,727
| New | +$1.73M | 0.02% | 146 |
|
|
2019
Q4 | – | Sell |
-30,600
| Closed | -$1.1M | – | 464 |
|
|
2019
Q3 | $1.1M | Buy |
+30,600
| New | +$1.1M | 0.01% | 266 |
|
|
2017
Q2 | – | Sell |
-9,664
| Closed | -$332K | – | 1109 |
|
|
2017
Q1 | $332K | Buy |
+9,664
| New | +$332K | ﹤0.01% | 607 |
|
|
2016
Q3 | – | Sell |
-112,100
| Closed | -$3.64M | – | 493 |
|
|
2016
Q2 | $3.64M | Buy |
+112,100
| New | +$3.64M | 0.06% | 110 |
|
|
2015
Q3 | – | Sell |
-7,385
| Closed | -$309K | – | 433 |
|
|
2015
Q2 | $309K | Buy |
+7,385
| New | +$309K | ﹤0.01% | 241 |
|
|
2014
Q2 | – | Sell |
-8,300
| Closed | -$202K | – | 137 |
|
|
2014
Q1 | $202K | Buy |
+8,300
| New | +$202K | 0.01% | 108 |
|